Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.12

-2.1%

Jan 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (3252)	5/8/2015 12:19:57 PM
From: Jibacoa	Read Replies (2) of 3722

SGEN opened today with a good UG. <g> The stock is up for 4th day on a roll.<g> Today's volume is already ahead of its ADV.<g> It has had upgrades form analysts, with "targets" around $51.<g> Thad said, it seem the stock has a good chance of closing some of today's UG Although it was able to go through the resistance from the Mar29-Mar30 double top. The next resistance now is the Aug-Sep2014 Hs at the $45 level, before it can try to test the Feb-Mar2014 Hs at the $55 level.<g> The possible catalysts to watch are potential FDA approval for Adcetris in the post-tranplant setting later this Yr. The data for ALCANZA, next Yr and the results for ECHELON-1 and ECHELON-2, sometime in 2017 or 2018. <g> The insiders did a good amount of buying last Q, but lately have been taking some profits after exercising options.<g> The insiders hold a good % of the shrs. Fidelity close to 15% <g> SGEN still has close to $300Ms in Csh, enough to keep burning at the prsent pace fo at least a couple of Yrs.<g> The stock performed well and had a good run from Apr2010 to the Mar2014 H. I did participate on some of that.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next